MX2009009428A - Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. - Google Patents
Analogos de ciclopamina heterociclicos y metodos de uso de los mismos.Info
- Publication number
- MX2009009428A MX2009009428A MX2009009428A MX2009009428A MX2009009428A MX 2009009428 A MX2009009428 A MX 2009009428A MX 2009009428 A MX2009009428 A MX 2009009428A MX 2009009428 A MX2009009428 A MX 2009009428A MX 2009009428 A MX2009009428 A MX 2009009428A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- cyclopamine analogs
- heterocyclic
- heterocyclic cyclopamine
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente invenci?n se relaciona a compuestos similares a alcaloides esteroidales que se pueden utilizar en el tratamiento de des?rdenes relacionados con la ruta hedgehog, particularmente c?ncer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89359507P | 2007-03-07 | 2007-03-07 | |
PCT/US2008/003200 WO2008109184A1 (en) | 2007-03-07 | 2008-03-07 | Heterocyclic cyclopamine analogs and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009009428A true MX2009009428A (es) | 2010-04-27 |
Family
ID=39738651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009009428A MX2009009428A (es) | 2007-03-07 | 2008-03-07 | Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. |
Country Status (15)
Country | Link |
---|---|
US (3) | US7648994B2 (es) |
EP (1) | EP2129677B1 (es) |
JP (1) | JP2010520295A (es) |
KR (1) | KR20090117957A (es) |
CN (1) | CN101687877B (es) |
AU (1) | AU2008223355B2 (es) |
BR (1) | BRPI0808663A2 (es) |
CA (1) | CA2680186A1 (es) |
HK (1) | HK1139657A1 (es) |
IL (1) | IL200684A0 (es) |
MX (1) | MX2009009428A (es) |
NZ (1) | NZ579361A (es) |
RU (1) | RU2009137014A (es) |
WO (1) | WO2008109184A1 (es) |
ZA (1) | ZA200906089B (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明(cyclopamine)類似物類 |
WO2008109829A1 (en) | 2007-03-07 | 2008-09-12 | Infinity Pharmaceuticals, Inc. | Cyclopamine lactam analogs and methods of use thereof |
RU2009137014A (ru) * | 2007-03-07 | 2011-04-20 | Инфинити Дискавери, Инк. (Us) | Гетероциклические аналоги циклопамина и способы их применения |
PE20091180A1 (es) * | 2007-12-27 | 2009-08-26 | Infinity Pharmaceuticals Inc | Tratamientos terapeuticos contra el cancer |
CN101917853B (zh) * | 2007-12-27 | 2014-03-19 | 无限药品股份有限公司 | 立体选择性还原的方法 |
US20100297118A1 (en) * | 2007-12-27 | 2010-11-25 | Macdougall John | Therapeutic Cancer Treatments |
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
US20110275576A1 (en) * | 2009-01-06 | 2011-11-10 | Utah State University | Carbohydrate-Cyclopamine Conjugates as Anticancer Agents |
CA2769795C (en) | 2009-08-05 | 2020-01-07 | Infinity Pharmaceuticals, Inc. | Enzymatic transamination of cyclopamine analogs |
US20110065645A1 (en) * | 2009-09-10 | 2011-03-17 | The Regents Of The University Of California | Compositions and Methods for Modulating Neuron Degeneration and Neuron Guidance |
WO2011057222A1 (en) * | 2009-11-06 | 2011-05-12 | Infinity Pharmaceuticals, Inc. | Oral formulations of a hedgehog pathway inhibitor |
US20110183948A1 (en) * | 2010-01-15 | 2011-07-28 | Infinity Pharmaceuticals, Inc. | Treatment of fibrotic conditions using hedgehog inhibitors |
WO2011146882A1 (en) | 2010-05-21 | 2011-11-24 | Intellikine, Inc. | Chemical compounds, compositions and methods for kinase modulation |
WO2012037217A1 (en) | 2010-09-14 | 2012-03-22 | Infinity Pharmaceuticals, Inc. | Transfer hydrogenation of cyclopamine analogs |
EP2637669A4 (en) | 2010-11-10 | 2014-04-02 | Infinity Pharmaceuticals Inc | Heterocyclic compounds and their use |
SG10201600179RA (en) | 2011-01-10 | 2016-02-26 | Infinity Pharmaceuticals Inc | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
EP2734520B1 (en) | 2011-07-19 | 2016-09-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
WO2013012918A1 (en) | 2011-07-19 | 2013-01-24 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
AU2012302197B2 (en) | 2011-08-29 | 2016-01-07 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
WO2013049332A1 (en) | 2011-09-29 | 2013-04-04 | Infinity Pharmaceuticals, Inc. | Inhibitors of monoacylglycerol lipase and methods of their use |
GB201202167D0 (en) * | 2012-02-08 | 2012-03-21 | Pratt Ian | A navigation device employing meshed networking technologies with associated camera device |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
DK2914296T4 (da) | 2012-11-01 | 2022-01-03 | Infinity Pharmaceuticals Inc | Behandling af cancere under anvendelse af PI3-kinase-isoform-modulatorer |
CA2893133A1 (en) | 2012-11-29 | 2014-06-05 | Strasspharma Llc | Methods of modulating follicle stimulating hormone activity |
WO2014151386A1 (en) | 2013-03-15 | 2014-09-25 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
US9192609B2 (en) | 2013-04-17 | 2015-11-24 | Hedgepath Pharmaceuticals, Inc. | Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors |
BR112015029969A2 (pt) | 2013-05-30 | 2017-07-25 | Infinity Pharmaceuticals Inc | tratamento de câncer usando moduladores de isoformas quinase pi3 |
US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
TWI657085B (zh) | 2013-10-04 | 2019-04-21 | 英菲尼提製藥股份有限公司 | 雜環化合物及其用途 |
WO2015061204A1 (en) | 2013-10-21 | 2015-04-30 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
ES2913486T3 (es) | 2014-03-19 | 2022-06-02 | Infinity Pharmaceuticals Inc | Compuestos heterocíclicos para la utilización en el tratamiento de trastornos mediados por PI3K-gamma |
WO2015160986A2 (en) | 2014-04-16 | 2015-10-22 | Infinity Pharmaceuticals, Inc. | Combination therapies |
WO2015168079A1 (en) | 2014-04-29 | 2015-11-05 | Infinity Pharmaceuticals, Inc. | Pyrimidine or pyridine derivatives useful as pi3k inhibitors |
WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
MX2017015681A (es) | 2015-06-04 | 2018-09-11 | Pellepharm Inc | Formulaciones topicas para suministrar compuestos inhibidores de hedgehog y uso de los mismos. |
US20170231968A1 (en) | 2016-02-11 | 2017-08-17 | PellePharm, Inc. | Method for relief of and treatment of pruritus |
WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
EP3474856B1 (en) | 2016-06-24 | 2022-09-14 | Infinity Pharmaceuticals, Inc. | Combination therapies |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2851054B2 (ja) | 1989-03-15 | 1999-01-27 | サントリー株式会社 | ベンズオキセピン誘導体 |
WO1995018856A1 (en) | 1993-12-30 | 1995-07-13 | President And Fellows Of Harvard College | Vertebrate embryonic pattern-inducing hedgehog-like proteins |
US6281332B1 (en) | 1994-12-02 | 2001-08-28 | The Johns Hopkins University School Of Medicine | Hedgehog-derived polypeptides |
US6238876B1 (en) | 1997-06-20 | 2001-05-29 | New York University | Methods and materials for the diagnosis and treatment of sporadic basal cell carcinoma |
US7709454B2 (en) | 1997-06-20 | 2010-05-04 | New York University | Methods and compositions for inhibiting tumorigenesis |
US6432970B2 (en) | 1998-04-09 | 2002-08-13 | Johns Hopkins University School Of Medicine | Inhibitors of hedgehog signaling pathways, compositions and uses related thereto |
US6867216B1 (en) | 1998-04-09 | 2005-03-15 | Johns Hopkins University School Of Medicine | Inhibitors of hedgehog signal pathways, compositions and uses related thereto |
US7291626B1 (en) | 1998-04-09 | 2007-11-06 | John Hopkins University School Of Medicine | Inhibitors of hedgehog signaling pathways, compositions and uses related thereto |
EP1105149A1 (en) | 1998-08-13 | 2001-06-13 | University Of Southern California | Methods to increase blood flow to ischemic tissue |
US6291516B1 (en) | 1999-01-13 | 2001-09-18 | Curis, Inc. | Regulators of the hedgehog pathway, compositions and uses related thereto |
ATE328002T1 (de) | 1999-10-13 | 2006-06-15 | Univ Johns Hopkins Med | Verbindungen zur regulierung des hedgehog- signalwegs, zusammensetzungen und verwendungen davon |
IL133809A0 (en) | 1999-12-30 | 2001-04-30 | Yeda Res & Dev | Steroidal alkaloids and pharmaceutical compositions comprising them |
US7708998B2 (en) | 2000-10-13 | 2010-05-04 | Curis, Inc. | Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
EP1387674B1 (en) | 2000-10-13 | 2017-01-18 | Curis, Inc. | Hedgehog antagonists, methods and uses related thereto |
JP2004534743A (ja) | 2001-04-09 | 2004-11-18 | ロランティス リミテッド | ヘッジホッグ |
EP1411938B1 (en) | 2001-07-02 | 2005-07-06 | Tas, Sinan | Use of cyclopamine for the manufacture of a medicament for the treatemnt of psoriasis |
BR0117063A (pt) | 2001-07-02 | 2004-07-27 | Sinan Tas | Uso de ciclopamina no tratamento de carcinoma de células basais e outros tumores |
US20030175355A1 (en) | 2002-03-07 | 2003-09-18 | Tobyn Michael John | Fast melt multiparticulate formulations for oral delivery |
GB0221539D0 (en) | 2002-09-17 | 2002-10-23 | Medical Res Council | Methods of treatment |
WO2005013800A2 (en) | 2003-07-15 | 2005-02-17 | The Johns Hopkins University | Elevated hedgehog pathway activity in digestive system tumors, and methods of treating digestive system tumors having elevated hedgehog pathway activity |
US20070231828A1 (en) | 2003-10-01 | 2007-10-04 | Johns Hopkins University | Methods of predicting behavior of cancers |
WO2005032343A2 (en) | 2003-10-01 | 2005-04-14 | The Johns Hopkins University | Hedgehog signaling in prostate regeneration neoplasia and metastasis |
WO2005042700A2 (en) | 2003-10-20 | 2005-05-12 | The Johns Hopkins University | Use of hedgehog pathway inhibitors in small-cell lung cancer |
EP2316833B1 (en) * | 2004-08-27 | 2016-03-30 | Infinity Pharmaceuticals, Inc. | Process for the preparation of Cyclopamine analogue compounds |
JP2008514726A (ja) | 2004-09-30 | 2008-05-08 | ザ ユニヴァーシティー オヴ シカゴ | ヘッジホッグ阻害剤、放射線及び化学療法薬の併用療法 |
US20090208579A1 (en) | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
US20080019961A1 (en) | 2006-02-21 | 2008-01-24 | Regents Of The University Of Michigan | Hedgehog signaling pathway antagonist cancer treatment |
WO2007123511A2 (en) | 2006-03-24 | 2007-11-01 | Infinity Pharmaceuticals, Inc. | Dosing regimens for the treatment of cancer |
US20100048944A1 (en) | 2006-07-19 | 2010-02-25 | Farhad Parhami | Interactions of hedgehog and liver x receptor signaling pathways |
TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明(cyclopamine)類似物類 |
WO2008089123A2 (en) | 2007-01-12 | 2008-07-24 | Infinity Discovery, Inc. | Methods for analysis of hedgehog pathway inhibitors |
WO2008109829A1 (en) | 2007-03-07 | 2008-09-12 | Infinity Pharmaceuticals, Inc. | Cyclopamine lactam analogs and methods of use thereof |
RU2009137014A (ru) | 2007-03-07 | 2011-04-20 | Инфинити Дискавери, Инк. (Us) | Гетероциклические аналоги циклопамина и способы их применения |
US7867492B2 (en) | 2007-10-12 | 2011-01-11 | The John Hopkins University | Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies |
CN101917853B (zh) * | 2007-12-27 | 2014-03-19 | 无限药品股份有限公司 | 立体选择性还原的方法 |
US20110217294A1 (en) | 2008-04-11 | 2011-09-08 | Daniel Fults | Combination of hgf inhibitor and hedgehog inhibitor to treat cancer |
CL2009001479A1 (es) | 2008-07-02 | 2010-01-04 | Infinity Pharmaceuticals Inc | Metodo para aislar un alcaloide del veratrum desglicosilado que comprende proporcionar un material de planta veratrum, poner en contacto con una solucion acuosa y extraer el material de la planta veratrum con un solvente para proporcionar un extracto que comprende dicho alcaloide. |
CA2636807A1 (en) | 2008-07-04 | 2010-01-04 | Steven Splinter | Methods for obtaining cyclopamine |
CA2769795C (en) * | 2009-08-05 | 2020-01-07 | Infinity Pharmaceuticals, Inc. | Enzymatic transamination of cyclopamine analogs |
WO2011057222A1 (en) | 2009-11-06 | 2011-05-12 | Infinity Pharmaceuticals, Inc. | Oral formulations of a hedgehog pathway inhibitor |
-
2008
- 2008-03-07 RU RU2009137014/04A patent/RU2009137014A/ru not_active Application Discontinuation
- 2008-03-07 MX MX2009009428A patent/MX2009009428A/es active IP Right Grant
- 2008-03-07 JP JP2009552770A patent/JP2010520295A/ja not_active Ceased
- 2008-03-07 EP EP08726695.3A patent/EP2129677B1/en active Active
- 2008-03-07 CN CN200880012734.4A patent/CN101687877B/zh not_active Expired - Fee Related
- 2008-03-07 WO PCT/US2008/003200 patent/WO2008109184A1/en active Application Filing
- 2008-03-07 KR KR1020097020903A patent/KR20090117957A/ko not_active Application Discontinuation
- 2008-03-07 BR BRPI0808663-0A patent/BRPI0808663A2/pt not_active IP Right Cessation
- 2008-03-07 US US12/044,817 patent/US7648994B2/en not_active Expired - Fee Related
- 2008-03-07 NZ NZ579361A patent/NZ579361A/en not_active IP Right Cessation
- 2008-03-07 CA CA002680186A patent/CA2680186A1/en not_active Abandoned
- 2008-03-07 AU AU2008223355A patent/AU2008223355B2/en not_active Ceased
-
2009
- 2009-09-01 IL IL200684A patent/IL200684A0/en unknown
- 2009-09-02 ZA ZA2009/06089A patent/ZA200906089B/en unknown
- 2009-12-02 US US12/629,382 patent/US7994191B2/en not_active Expired - Fee Related
-
2010
- 2010-06-08 HK HK10105627.8A patent/HK1139657A1/xx not_active IP Right Cessation
-
2011
- 2011-06-24 US US13/168,590 patent/US8426436B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20080293755A1 (en) | 2008-11-27 |
US8426436B2 (en) | 2013-04-23 |
US20100144775A1 (en) | 2010-06-10 |
JP2010520295A (ja) | 2010-06-10 |
CN101687877A (zh) | 2010-03-31 |
AU2008223355A1 (en) | 2008-09-12 |
US20120065218A1 (en) | 2012-03-15 |
CA2680186A1 (en) | 2008-09-12 |
US7648994B2 (en) | 2010-01-19 |
RU2009137014A (ru) | 2011-04-20 |
US7994191B2 (en) | 2011-08-09 |
IL200684A0 (en) | 2010-05-17 |
BRPI0808663A2 (pt) | 2014-08-26 |
ZA200906089B (en) | 2011-02-23 |
AU2008223355B2 (en) | 2014-03-20 |
HK1139657A1 (en) | 2010-09-24 |
KR20090117957A (ko) | 2009-11-16 |
EP2129677A1 (en) | 2009-12-09 |
NZ579361A (en) | 2012-04-27 |
CN101687877B (zh) | 2014-07-23 |
EP2129677B1 (en) | 2014-12-17 |
WO2008109184A1 (en) | 2008-09-12 |
EP2129677A4 (en) | 2012-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009009428A (es) | Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. | |
HK1139930A1 (en) | Cyclopamine lactam analogs and methods of use thereof | |
IN2015DN01156A (es) | ||
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
MX2009009491A (es) | Compuestos y composiciones como moduladores de la actividad del gpr119. | |
GB0906579D0 (en) | Pharmaceuticals, compositions and methods of making and using the same | |
MX365294B (es) | Inhibidores de proteína cinasa dependiente de adn. | |
MX2010002732A (es) | Inhibidores de f1f0-atpasa y metodos relacionados. | |
MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
MX2009006706A (es) | Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos. | |
MX2009010960A (es) | Compuestos heterociclicos y sus metodos de uso. | |
MX2010000098A (es) | Derivados de guanina policiclicos y sus metodos de uso. | |
MX2012000396A (es) | Metodos y composiciones para uso en tartamientos celulares. | |
IL202317A0 (en) | Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer | |
SI2176252T1 (sl) | 2,3-dihidrobenzo(1,4)dioksin-2-ilmetilni derivati kot alfa2C antagonisti za uporabo v zdravljenju bolezni perifernega in centralnega živčnega sistema | |
IN2012DN02471A (es) | ||
TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
EA201071248A1 (ru) | Дизамещенные фталазиновые антагонисты пути hedgehog | |
MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
ZA201003352B (en) | Heterocyclic derivatives as modulators of ion channels | |
MX2014000964A (es) | Derivados aza heterociclicos sustituidos. | |
MX2009009190A (es) | Compuestos heterociclicos, composiciones que los comprenden y metodos que los emplean. | |
EP2217238A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO PROTEINURIA | |
MX342119B (es) | 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |